05:19 PM EST, 11/11/2025 (MT Newswires) -- Sanara MedTech ( SMTI ) said Tuesday it is discontinuing operations of its Tissue Health Plus division after completing an evaluation of strategic alternatives.

The company said the move is intended to improve operating efficiency and reallocate resources to its core surgical business.

The winding down of Tissue Health Plus is expected to continue through the end of 2025.

Sanara reiterated that it expects total cash investment in the business to range from $5.5 million to $6.5 million in H2 2025, and said it does not expect to incur material cash expenses related to the segment after year-end.